BETAMETHASONE DIPROPRIONATE 0.05% / MINOXIDIL 7%- betamethasone diproprionate 0.05% / minoxidil 7% solution 
Sincerus Florida, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

BETAMETHASONE DIPROPRIONATE 0.05% / MINOXIDIL 7%

Directions for use

fh

Sincerus Florida, LLC. Adverse reactions

X

Active, inactive

ss

NDC 72934-4025-8. BETAMETHASONE DIPROPRIONATE USP 0.05% / MINOXIDIL USP 7%. Solution 60 gm

zc

BETAMETHASONE DIPROPRIONATE 0.05% / MINOXIDIL 7% 
betamethasone diproprionate 0.05% / minoxidil 7% solution
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:72934-4025
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BETAMETHASONE DIPROPIONATE (UNII: 826Y60901U) (BETAMETHASONE - UNII:9842X06Q6M) BETAMETHASONE0.05 g  in 100 g
MINOXIDIL (UNII: 5965120SH1) (MINOXIDIL - UNII:5965120SH1) MINOXIDIL7 g  in 100 g
Product Characteristics
Colorwhite (clear solution) Score    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72934-4025-860 g in 1 BOTTLE, GLASS; Type 0: Not a Combination Product05/10/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/10/2019
Labeler - Sincerus Florida, LLC (080105003)
Establishment
NameAddressID/FEIBusiness Operations
Sincerus Florida, LLC080105003manufacture(72934-4025)

Revised: 5/2019
Document Id: 8875a838-5a95-3407-e053-2a95a90ae3eb
Set id: 8875a838-5a94-3407-e053-2a95a90ae3eb
Version: 1
Effective Time: 20190509
 
Sincerus Florida, LLC